Pain News and Research

Latest Pain News and Research

Research uncovers how parasitic worms evade itch response

Ever had an itchy nose or, worse, an unreachable spot on your back that drives you mad? Now imagine an itch that refuses to go away, no matter how hard or long you scratch.

26 Oct 2024

Ipsen's elafibranor recommended for use in patients with rare liver disease

Ipsen announced today that the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg tablets for the treatment of PBC in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA. This makes elafibranor the first medicine for PBC approved for use on the NHS in nearly a decade.

26 Oct 2024

Study reveals misuse of scientific evidence by opioid makers

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that makers and marketers of prescription opioid painkillers misused scientific evidence to advance five common and inaccurate claims about the safety and effectiveness of prescription opioids-;including that they were not addictive.

25 Oct 2024

Researchers unlock potential of light-controlled cellular activities

Researchers at the Paul Scherrer Institute PSI have succeeded in elucidating the structure of specific photoreceptors.

25 Oct 2024

The hidden effects of opioid use on the endocrine system

A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.

25 Oct 2024

Are back problems influenced by your gut?

Findings suggest gut microbiome dysbiosis may influence lumbar degenerative spondylolisthesis, impacting inflammation and pain management strategies.

25 Oct 2024

New technology enables targeted delivery of antibiotics

Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in one tiny dose and deliver on demand just the right amount of medication that a particular patient needs to fight an infection.

24 Oct 2024

Innovative pain assessment tool receives $8 million funding

Pain assessment in medicine often relies on imprecise visual rating scales featuring smiling or crying faces, frustrating patients and physicians alike. Children's National Hospital researchers aim to change this with a new device designed to precisely measure pain, backed by an $8-million award from the Advanced Research Projects Agency for Health (ARPA-H) Sprint for Women's Health.

24 Oct 2024

Novel device may rescue people from overdose without bystander help

The opioid epidemic claims more 70,000 lives each year in the U.S., and lifesaving interventions are urgently needed.

23 Oct 2024

Many polio survivors face lifelong late effects

Polio survivors facing the little-known late effects of the disease are being overlooked, writes Neena Bhandari.

23 Oct 2024

First wearable camera system detects medication errors with AI

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence, detects potential errors in medication delivery.

22 Oct 2024

Axol Bioscience acquires Phenocell to advance human disease models

Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug discovery, today announced it has fully acquired Phenocell SAS, a pioneer in iPSC-based products and bioassays for skin and retinal disorders.

From Axol Bioscience Ltd 22 Oct 2024

Black patients face higher risks following coronary artery bypass grafting

Despite advances in cardiovascular medicine, Black patients are 22% more likely than white patients to die in the hospital after coronary artery bypass grafting (CABG) surgery, according to a study of more than 1 million patients presented at the ANESTHESIOLOGY 2024 annual meeting.

21 Oct 2024

Methadone more effective than buprenorphine in reducing treatment discontinuation

People with opioid use disorder in British Columbia who received methadone had a 37–40 per cent lower rate of treatment discontinuation compared with those who received buprenorphine/naloxone.

21 Oct 2024

Long-term antiviral treatment may protect vision from shingles

Taking an antiviral medication for a year may prevent vision damage associated with shingles that affects the eye, according to new research led by faculty from the Perelman School of Medicine at the University of Pennsylvania and the NYU Grossman School of Medicine.

21 Oct 2024

Study reveals racial bias in postsurgical analgesia

While recovering from major surgery, Black patients may be less likely to receive certain multimodal analgesia options and more likely to receive oral opioids than white patients, according to research being presented at the ANESTHESIOLOGY® 2024 annual meeting.

21 Oct 2024